123 results
Page 3 of 7
8-K
EX-99.2
xb0gvh
30 Mar 23
Centessa Pharmaceuticals Reports Recent Business Progress and Financial Results for the Fourth Quarter and Full-Year 2022
7:19am
8-K
EX-99.1
e8ubkj8g1n20
12 Dec 22
Regulation FD Disclosure
6:37am
8-K
ll6afgdadsg3p1xq
6 Oct 22
Other Events
5:06pm
8-K
EX-3.1
q4gm6 v3h
6 Oct 22
Other Events
5:06pm
8-K
EX-99.1
en10u ym02
12 Sep 22
Regulation FD Disclosure
7:16am
S-3
EX-4.4
rd5j23 6k
1 Jul 22
Shelf registration
4:06pm
S-3
300rs 6uqd0
1 Jul 22
Shelf registration
4:06pm
S-3
EX-5.1
kmg2fce1
1 Jul 22
Shelf registration
4:06pm
S-3
EX-4.6
q9lerwhj jbni3w
1 Jul 22
Shelf registration
4:06pm
S-8
EX-5.1
9d8x3ggh
1 Jul 22
Registration of securities for employees
4:06pm
S-8
qoai ok5zqqima
1 Jul 22
Registration of securities for employees
4:06pm
8-K
bibere1dn0kbi3be6z
30 Jun 22
Submission of Matters to a Vote of Security Holders
4:34pm
DEFA14A
qm4ue
9 Jun 22
Additional proxy soliciting materials
9:06am
8-K
EX-99.2
j4tj2fhlrbt i86umnp
2 Jun 22
Cost Associated with Exit or Disposal Activities
6:33am
DEF 14A
mg04egaz68czo oopnb
23 May 22
Definitive proxy
8:00am
10-K/A
elvg3r 6abp15cn8
2 May 22
Annual report (amended)
4:30pm
8-K
EX-99.2
mtsvke73cjwsi ahyyt
30 Mar 22
Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update
4:06pm